Gene Expression Meta-Analysis Identifies VDAC1 as a Predictor of Poor Outcome in Early Stage Non-Small Cell Lung Cancer
2011

VDAC1 Predicts NSCLC Survival

Sample size: 602 publication Evidence: high

Author Information

Author(s): Claire Grills, Jithesh Puthen V., Jaine Blayney, Shu-Dong Zhang, Dean A. Fennell

Primary Institution: Queen's University Belfast

Hypothesis

VDAC1 expression could impact survival following NSCLC resection.

Conclusion

High VDAC1 expression is associated with shorter overall survival in non-small cell lung cancer.

Supporting Evidence

  • High VDAC1 expression was associated with shorter overall survival.
  • VDAC1 was shown to be an independent prognostic factor.
  • VDAC1 predicted shorter time to recurrence following NSCLC resection.
  • Analysis included 8 independent NSCLC datasets.

Takeaway

This study found that a protein called VDAC1 can help predict how long patients with lung cancer will live after surgery.

Methodology

In vivo gene-expression meta-analysis of surgically resected NSCLC using 602 individual expression profiles.

Limitations

The study had a low number of samples for stages II and III, making it difficult to obtain statistically significant results.

Statistical Information

P-Value

0.0353

Confidence Interval

0.4528 to 0.9721

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0014635

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication